The Polyglycolic acid (PGA) chemical is gaining attention in Vietnam as healthcare providers and manufacturers explore advanced biodegradable materials for medical applications. Known for its strength, biocompatibility, and controlled degradation properties, PGA is widely used in absorbable sutures and is being researched for medical devices, tissue engineering, and drug delivery solutions. Vietnam’s expanding healthcare infrastructure and rising demand for advanced medical technologies are creating new opportunities for PGA-based products. The country’s medical device market reached approximately USD 1.9 billion in 2024, highlighting growing demand for innovative healthcare solutions and specialized materials.
Market Drivers Expanding PGA Opportunities in Vietnam
Healthcare Modernization Increases Demand for Bioabsorbable Materials
Vietnam’s improving healthcare infrastructure is creating stronger demand for advanced medical products. PGA’s established role in absorbable sutures makes it valuable for surgical procedures requiring temporary support before natural degradation. Rising investments in hospitals, increasing access to specialized treatments, and greater adoption of modern surgical techniques are encouraging interest in biodegradable medical materials. With Vietnam continuing to upgrade healthcare facilities and expand medical capabilities, demand for reliable biomaterials is expected to grow.
Medical Device Growth Opens New Applications for PGA
Vietnam’s medical device sector is becoming an important opportunity area for advanced polymer suppliers. The market is projected to grow at an 8.2% CAGR between 2024 and 2029, supported by healthcare infrastructure development and increasing demand for better-quality medical equipment. PGA-based materials can support applications ranging from surgical products to specialized medical devices, creating opportunities for manufacturers that can provide high-performance and application-specific polymer solutions.
Biotechnology Research Encourages Advanced Polymer Adoption
Beyond traditional surgical applications, PGA and related biodegradable polymers such as PLGA are being explored for controlled drug delivery, regenerative medicine, and tissue engineering. Vietnam’s growing pharmaceutical sector, valued at approximately USD 6.4 billion in 2024, is creating a stronger ecosystem for healthcare innovation and advanced material development. As research capabilities improve, biodegradable polymers could find broader applications in next-generation therapies.
Government Initiatives Supporting PGA Industry Growth in Vietnam
Vietnam’s government continues to strengthen healthcare infrastructure, medical technology adoption, and domestic manufacturing capabilities. The Ministry of Health oversees medical device regulations, standards, and approvals, creating a structured environment for healthcare product development. Recent policy efforts focused on improving medical equipment management and supporting healthcare modernization are encouraging investment in advanced medical solutions, including biomaterial-based products.
Competitive Landscape of Vietnam’s PGA Industry
Vietnam’s PGA market includes international polymer suppliers, medical device companies, healthcare manufacturers, and research organizations. Since advanced biomaterials require specialized expertise, companies are competing through product quality, regulatory knowledge, customized formulations, and technical support. Partnerships between material developers and healthcare providers are becoming increasingly important for introducing innovative PGA-based solutions into Vietnam’s medical ecosystem.
Challenges Affecting the PGA Market Expansion in Vietnam
Limited Domestic Production Creates Supply Dependence
Vietnam continues to rely heavily on imported medical technologies, with around 90% of medical equipment sourced from overseas. Similar challenges exist for specialized biomaterials, where advanced manufacturing capabilities and high-purity polymer production remain limited. Strengthening domestic expertise and supply networks will be important for long-term PGA market development.
High Costs and Regulatory Requirements Slow Adoption
Medical-grade PGA requires strict quality control, advanced processing capabilities, and regulatory approvals before commercialization. These requirements can increase development costs and extend timelines, particularly for companies entering new applications. Businesses need strong technical capabilities and regulatory expertise to successfully introduce PGA-based products in Vietnam.
Future Outlook
In the coming years, Vietnam’s polyglycolic acid market is expected to benefit from healthcare expansion, rising medical device demand, and growing interest in biodegradable materials. Absorbable sutures will remain a key application, while opportunities in drug delivery, tissue engineering, and advanced medical devices can further expand PGA adoption. As Vietnam continues modernizing its healthcare system and strengthening local manufacturing capabilities, companies investing in polymer innovation, strategic partnerships, and cost-efficient production can capture emerging opportunities in the country’s evolving biomaterials landscape.
Consultants at Nexdigm, in their latest publication “Vietnam Polyglycolic Acid Market Outlook to 2035,” analyze the sector By Form Type (PGA Fibers, Films, Resin Plates, Rods and Composites), By End-Use Industry (Medical, Oil and Gas, Packaging and Civil Engineering), By Grade (Medical, Oilfield, Packaging, Industrial, High Performance and Biodegradable).
Nexdigm suggests that businesses in Vietnam’s Polyglycolic Acid Industry should invest in polymer innovation, and expand applications across medical devices, drug delivery, and advanced healthcare solutions. Companies should focus on improving production efficiency and building strategic partnerships to capture emerging opportunities in India’s growing biomaterials ecosystem.
To take the next step, simply visit our Request a Consultation page and share your requirements with us.
Harsh Mittal
+91-8422857704